A Phase I And Randomized Phase 2 Trial Of Epothilone B Analogue BMS 247550 (NSC 710428) [ixabepilone] Administered Every 21 Days With Or Without Oral Estramustine Phosphate In Patients With Androgen Independent Prostate Cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Ixabepilone (Primary) ; Estramustine
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Sep 2005 New trial record.